Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Heart Surg Forum ; 22(3): E234-E240, 2019 05 24.
Artículo en Inglés | MEDLINE | ID: mdl-31237550

RESUMEN

BACKGROUND: The aim of our study was to compare the outcome of patients who underwent mitral valve anterior leaflet repair with and without chordal replacement for degenerative mitral valve insufficiency. METHODS: This study was conducted at our center between May 2006 and May 2013. The study included 125 patients with degenerative mitral valve insufficiency (64 males, 61 females; mean age 47 years, age range 16-78 years) who underwent mitral valve repair with anterior leaflet procedures. The patients were divided into 2 groups. Group A consisted of 56 patients with chordal replacement, and group B consisted of 69 patients with other repair techniques performed. RESULTS: No significant difference was determined between the 2 groups in mortality, recurrence, and reoperation rates. The mortality rate was 3.6% in group A and 1.4% in group B. During the follow-up period, 3 patients were reoperated on (mitral valve replacement) because of severe mitral valve insufficiency. Two of these patients were from group A (3.6%), and the other was from group B (1.4%). One patient in group A underwent intraoperative mitral valve replacement after unsuccessful chordal replacement. Fifty patients (89.3%) in group A and 65 patients (94.2%) in group B exhibited no or mild recurrence of mitral valve insufficiency. CONCLUSION: Mitral valve repair in patients with degenerative mitral valve insufficiency resulting from anterior leaflet pathology is a safe procedure because of its durability and good long-term results. Despite the difficulty of the chordal replacement procedure, it may be used as an alternative technique for anterior mitral valve leaflet repair.


Asunto(s)
Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Anuloplastia de la Válvula Mitral/efectos adversos , Insuficiencia de la Válvula Mitral/cirugía , Complicaciones Posoperatorias/epidemiología , Adolescente , Adulto , Anciano , Estudios de Cohortes , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Reoperación , Tasa de Supervivencia , Resultado del Tratamiento , Adulto Joven
2.
Turk Kardiyol Dern Ars ; 47(2): 122-127, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30874505

RESUMEN

OBJECTIVE: A study of the T wave peak-to-end (Tp-e) interval, the Tp-e/QT ratio, and the Tp-e/QTc ratio in pediatric heart transplant recipients (HTRs), a group which has a higher risk of sudden cardiac death than the normal population, has not previously been reported. The aim of this study was to assess alterations in ventricular repolarization using the Tp-e interval, Tp-e/ QT ratio, and Tp-e/QTc ratio in clinically stable pediatric HTRs. METHODS: A total of 13 clinically stable HTRs, 13 patients who had undergone cardiac surgery (CS) under cardiopulmonary bypass, and 16 healthy controls under 18 years of age were retrospectively evaluated. RESULTS: No significant differences were observed between the HTR, CS, and control groups in terms of QTc, JTc interval, and T wave amplitude (p>0.05). The Tp-e interval (p=0.001), Tp-e/QT ratio (p<0.001), and Tp-e/QTc ratio (p=0.001) were significantly higher in the HTR group compared with the CS and normal control participants. CONCLUSION: The Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio were elevated in stable HTRs compared with the normal and CS groups.


Asunto(s)
Arritmias Cardíacas/fisiopatología , Trasplante de Corazón , Adolescente , Estudios de Casos y Controles , Niño , Electrocardiografía , Femenino , Sistema de Conducción Cardíaco , Cardiopatías Congénitas/cirugía , Humanos , Masculino
3.
Heart Lung Circ ; 23(12): 1175-8, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25153357

RESUMEN

OBJECTIVES: The aim of this study was to evaluate the clinical outcome of patients who underwent TVR focusing on long-term survival- and valve-related complications. METHODS: Between January 1993 and June 2011, 132 patients underwent tricuspid valve replacement in our centre. Sixty-eight bioprosthetic valves (52%) and 64 mechanical valves (48%) were implanted for tricuspid position. For 51 patients (39%) this was a first-time tricuspid valve operation. RESULTS: Nineteen patients died during hospitalisation, yielding a hospital mortality rate of 14%. The hospital mortality and morbidity were not statistically significantly different between the two groups. Sixteen patients (14,1%) died after discharge from the hospital. Twelve-year actuarial survival after mechanical and bioprosthetic TVR was 72,1±5,9 and 61.6±6,6%, respectively. No statistically significant difference was detected between mechanical and bioprosthetic valves in regard to event-free survival. CONCLUSION: The choice between mechanical or biological prostheses in the tricuspid position should be individualised according to the clinical judgment, even though absence of any difference in the survival data supports the opinion that there is no "gold standard" for prosthetic tricuspid valve replacement.


Asunto(s)
Enfermedades de las Válvulas Cardíacas , Prótesis Valvulares Cardíacas , Válvula Tricúspide/cirugía , Anciano , Bioprótesis , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Enfermedades de las Válvulas Cardíacas/mortalidad , Enfermedades de las Válvulas Cardíacas/cirugía , Implantación de Prótesis de Válvulas Cardíacas , Mortalidad Hospitalaria , Humanos , Masculino , Persona de Mediana Edad , Tasa de Supervivencia , Factores de Tiempo
4.
Anadolu Kardiyol Derg ; 14(3): 286-91, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24566554

RESUMEN

OBJECTIVE: The main purpose of this study was to assess the patency of left internal thoracic artery (LITA) graft by using color Doppler ultrasonography (CDUSG) and furthermore to determine the sensitivity and specificity of CDUSG for patency by using coronary angiography as the reference standard. METHODS: This study is an observational cohort study on diagnostic accuracy that was held between August 2008 and October 2009. CDUSG was performed in 138 consecutive patients who had angina symptom or positive ischemic findings following coronary artery bypass surgery. LITA blood flow velocity at peak-systole (PSV), diastole (PDV) and end-diastole (EDV) was recorded. All patients were also assessed by coronary angiography for LITA graft patency. Statistical analysis was performed by using independent samples t-test, Mann-Whitney U test, chi-square test and receiver operating curve analyses (ROC). RESULTS: Seventy-eight of all patients had functional LITA grafts and 59 patients had dysfunctional LITA grafts according to CDUSG-derived parameters, whereas we cannot conclude about one patient's LITA graft functionality. The LITA grafts were visualized angiographically in all cases. Of all 138 patients, 60 patients had dysfunctional LITA grafts after angiographic evaluation. The ROC analyses showed that PDV (AUC=0.899, 95% CI 0.844 to 0.953; p<0.001) and EDV (AUC=0.900; 95% CI 0.847 to 0.953; p<0.001) values were also strongly associated with graft functionality. We found out that CDUSG predicts LITA graft functionality with a sensitivity and specificity of 100% and 98.4% respectively. The accuracy of the CDUSG was calculated as 99.3%. CONCLUSION: CDUSG is a reliable non-invasive method for assessment of LITA graft patency.


Asunto(s)
Enfermedad de la Arteria Coronaria/cirugía , Arterias Mamarias/fisiopatología , Grado de Desobstrucción Vascular , Anciano , Velocidad del Flujo Sanguíneo , Estudios de Cohortes , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/patología , Ecocardiografía Doppler en Color , Femenino , Humanos , Anastomosis Interna Mamario-Coronaria , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Flujo Pulsátil , Curva ROC
5.
J Cardiothorac Surg ; 8: 91, 2013 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-23590976

RESUMEN

BACKGROUND: An elevated mean platelet volume is associated with increased platelet activation and thus may predict thrombotic events. The goal of this study was to investigate the association of the mean platelet volume and the major adverse events after coronary artery bypass surgery. METHODS: Baseline clinical details and preoperative hematologic parameters were obtained prospectively in 205 consecutive patients undergoing coronary artery bypass surgery. Postoperative mortality and major adverse events were recorded in the early postoperative period (median of 72 days, interquartile range 58.5-109 days). RESULTS: Combined adverse events occurred in 37 patients (18.0%) during the early follow-up. The preoperative mean platelet volume and hematocrit levels were found to be associated with postoperative adverse events (p<0.001 for both variables). In multivariate logistic regression models, the preoperative mean platelet volume and hematocrit levels were strong independent predictors of combined adverse events after surgery (respectively OR 1.89, p=0.037; OR 0.87, p=0.011). After receiver-operating-characteristics curve analysis, using a cut-point of 8.75 fL, the preoperative mean platelet volume level predicted adverse events with a sensitivity of 54% and specificity of 70%. In a further model with cut-off points, higher preoperative mean platelet volume levels remained a powerful independent predictor of postoperative myocardial infarction (OR 3.60, p=0.013) and major adverse cardiac events (OR 2.53, p=0.045). CONCLUSIONS: An elevated preoperative mean platelet volume is associated with an adverse outcome after coronary artery bypass grafting. In conclusion, we can say that mean platelet volume is an important, simple, readily available, and cost effective tool and can be useful in predicting the postoperative adverse events in patients undergoing coronary artery bypass grafting.


Asunto(s)
Puente de Arteria Coronaria , Enfermedad de la Arteria Coronaria/cirugía , Volúmen Plaquetario Medio , Complicaciones Posoperatorias/etiología , Adulto , Anciano , Anciano de 80 o más Años , Puente de Arteria Coronaria/mortalidad , Enfermedad de la Arteria Coronaria/sangre , Enfermedad de la Arteria Coronaria/mortalidad , Femenino , Hematócrito , Humanos , Incidencia , Modelos Logísticos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/mortalidad , Periodo Preoperatorio , Estudios Prospectivos , Curva ROC , Medición de Riesgo , Factores de Riesgo , Sensibilidad y Especificidad
6.
Clin Hemorheol Microcirc ; 47(1): 27-35, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21321405

RESUMEN

Microvascular dysfunction is implicated in the pathogenesis of slow coronary flow (SCF), but less attention has been paid to intrinsic properties of blood that can also impair the microcirculatory flow. In this study we aimed to evaluate the blood viscosity focusing on erythrocyte aggregation, erythrocyte deformability and plasma viscosity in SCF. Thirty-three patients with SCF (21 male, 54 ± 12.8 years) and 23 subjects with normal coronary arteries (13 male, 59 ± 10.3 years) were included in the study. Coronary flow was quantified by means of thrombolysis in myocardial infarction (TIMI) frame count and aggregation and deformability of erythrocytes were measured by an ektacytometer. Plasma viscosity was measured by a cone-plate viscometer. Aggregation amplitude (23 ± 3.8 au vs. 15.7 ± 6.1 au, respectively, p < 0.001) and area A index (area above syllectogram) (153.2 ± 30.7 au.s vs. 124.9 ± 49.3 au.s, respectively, p < 0.01) were higher in SCF patients. Aggregation half-time, aggregation index, elongation index and plasma viscosity values were similar between two groups. Correlation analysis revealed a significant relationship between the TIMI frame count for left anterior descending artery and aggregation amplitude in SCF patients (r = 0.679, p < 0.0001). The result of this study reveals changes in erythrocyte aggregation which may contribute to the pathophysiology of SCF. Larger studies are needed to make more robust conclusions on this issue.


Asunto(s)
Viscosidad Sanguínea , Circulación Coronaria , Adulto , Anciano , Angiografía Coronaria , Estudios Transversales , Agregación Eritrocitaria , Deformación Eritrocítica , Femenino , Humanos , Masculino , Persona de Mediana Edad
7.
Ann Vasc Surg ; 24(6): 775-85, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20471213

RESUMEN

BACKGROUND: The aim of this study was to assess the effect of gender on mortality and morbidity in carotid endarterectomy (CEA) patients. METHODS: Forty-one female and 150 male patients who underwent isolated CEA operations, between 1994 and 2007, were included in this study. To find the role of gender in isolated CEA operations, patients with a previous history of cardiac operations, coronary interventions, and a staged cardiac and/or vascular operation were excluded from the study. RESULTS: In the postoperative period, one female patient (2.4%) and 8 male patients (4.9%) had neurological complications (p > 0.05). Hospital mortality rates of female and male groups were 0.0% and 2.4%, respectively (p > 0.05). Perioperative events which cause significant increase in hospital mortality were myocardial ischemia, low cardiac output, and need of intra-aortic balloon pump (p = 0.0001). Late mortality rates of female and male groups were 7.5% and 9.9%, respectively. The actuarial survival rate was 82.2 +/- 11.6% in women and 71.5 +/- 7.5% in men for a mean period of 36.4 +/- 29.1 months (p > 0.05). All the observed mortalities in the long term were cardiac-related or with other causes, no neurological deaths observed in both groups (p > 0.05). According to logistic regression analysis smoking and peripheral arterial disease were found as statistically significant risk factors for late mortality. CONCLUSION: Female gender is not a risk factor for stroke or death after CEA. Women should not be excluded from the benefits of CEA and gender should not be a consideration in the decision to perform it.


Asunto(s)
Endarterectomía Carotidea/efectos adversos , Anciano , Distribución de Chi-Cuadrado , Endarterectomía Carotidea/mortalidad , Femenino , Mortalidad Hospitalaria , Humanos , Estimación de Kaplan-Meier , Modelos Logísticos , Masculino , Persona de Mediana Edad , Selección de Paciente , Enfermedades Vasculares Periféricas/complicaciones , Enfermedades Vasculares Periféricas/mortalidad , Medición de Riesgo , Factores de Riesgo , Factores Sexuales , Fumar/efectos adversos , Fumar/mortalidad , Factores de Tiempo , Resultado del Tratamiento , Turquía
8.
J Card Surg ; 25(4): 382-4, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20412354

RESUMEN

We present a case of a displaced atrial septal defect (ASD) occluder in the left ventricle. We successfully adapted a strategy to remove the device through a single right atrial incision which permitted retrieval of the occluder and the closure of the ASD.


Asunto(s)
Atrios Cardíacos/cirugía , Defectos del Tabique Interatrial/cirugía , Tabiques Cardíacos/cirugía , Dispositivo Oclusor Septal/efectos adversos , Ecocardiografía Transesofágica , Falla de Equipo , Femenino , Atrios Cardíacos/diagnóstico por imagen , Defectos del Tabique Interatrial/diagnóstico por imagen , Tabiques Cardíacos/diagnóstico por imagen , Ventrículos Cardíacos , Humanos , Adulto Joven
9.
Interact Cardiovasc Thorac Surg ; 10(6): 948-52, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20233805

RESUMEN

Unilateral selective cerebral perfusion through right brachial artery is one of the cerebral protection methods for aortic arch repair. The purpose of this study is to determine whether cerebral perfusion through contra-lateral hemisphere is adequate or not. Seventeen consecutive patients underwent aortic arch repair using low flow antegrade selective cerebral perfusion (ASCP) through right brachial artery under moderate hypothermia. We measured S100beta and neuron-specific enolase (NSE) levels, venous O(2) saturation, lactate, and glucose from both left and right jugular vein blood samples before, during and following ASCP and cardiopulmonary bypass. There was no operative mortality or neurological complication in these patients. No significant differences were observed in S100beta and NSE levels, venous saturation, glucose and lactate between the blood samples which were gathered from both jugular veins, statistically. This technique, as far as biochemical markers are concerned, seems to provide adequate perfusion for both right and left cerebral hemispheres.


Asunto(s)
Enfermedades de la Aorta/cirugía , Arteria Braquial , Cateterismo Periférico , Circulación Cerebrovascular , Cerebro/irrigación sanguínea , Factores de Crecimiento Nervioso/sangre , Perfusión/métodos , Fosfopiruvato Hidratasa/sangre , Proteínas S100/sangre , Procedimientos Quirúrgicos Vasculares , Adulto , Anciano , Aorta Torácica/cirugía , Enfermedades de la Aorta/sangre , Enfermedades de la Aorta/fisiopatología , Biomarcadores/sangre , Glucemia/metabolismo , Puente Cardiopulmonar , Trastornos Cerebrovasculares/sangre , Trastornos Cerebrovasculares/etiología , Trastornos Cerebrovasculares/fisiopatología , Trastornos Cerebrovasculares/prevención & control , Femenino , Humanos , Ácido Láctico/sangre , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Subunidad beta de la Proteína de Unión al Calcio S100 , Factores de Tiempo , Procedimientos Quirúrgicos Vasculares/efectos adversos
10.
J Card Surg ; 24(2): 141-2, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19267820

RESUMEN

The hammock mitral valve is a rare congenital abnormality resulting in mitral regurgitation or stenosis, with incidences ranging from 0% to 12% in pediatric surgical series. It is difficult to correct this condition by reconstructive techniques. We describe here an alone hammock valve without any cardiac malformation in a five-year-old patient who underwent mitral valve replacement.


Asunto(s)
Prótesis Valvulares Cardíacas , Insuficiencia de la Válvula Mitral/cirugía , Válvula Mitral/cirugía , Preescolar , Implantación de Prótesis de Válvulas Cardíacas , Humanos , Masculino , Válvula Mitral/anomalías , Válvula Mitral/diagnóstico por imagen , Válvula Mitral/patología , Insuficiencia de la Válvula Mitral/diagnóstico por imagen , Insuficiencia de la Válvula Mitral/patología , Ultrasonografía
12.
J Cardiovasc Pharmacol ; 52(6): 518-23, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19034033

RESUMEN

BACKGROUND: To evaluate whether ambroxol administered orally during the perioperative period has a protective effect against postoperative pulmonary dysfunction in on-pump coronary artery bypass surgery. METHODS: Fifty younger patients without known pulmonary disease were randomly assigned into 2 groups. In ambroxol group (n = 25), patients were given ambroxol for a week before and after the elective coronary artery bypass grafting. In control group (n = 25), placebo was given. Groups were compared with respect to pulmonary function tests (PFTs), lecithin/sphingomyelin (L/S) ratio in the bronchoalveolar lavage fluid, arterial blood gases, and incidence of perioperative morbidity. PFTs were performed before medication and repeated on the postoperative seventh day. Bronchoalveolar lavage fluid was obtained just before cardiopulmonary bypass and within the first postoperative hour. Room air arterial blood gases were checked before and 2 days after the operation. RESULTS: Postoperative lecithin/sphingomyelins were significantly lower than the preoperative values in both groups, but differences between the groups in either preoperative or postoperative measurements were not significant. Although preoperative PaO2 in both groups was similar, it was significantly lower in control group on postoperative second day (62.4 +/- 7.1 vs. 55.2 +/- 6.4 mm Hg, P < 0.05). In either groups, postoperative forced vital capacity and forced expiratory volume in 1 second were significantly lower than preoperative values with a more prominent decrease in control group. Perioperative morbidity was similar. CONCLUSIONS: In on-pump coronary artery bypass grafting, ambroxol improves postoperative PFTs and PaO2 levels without any significant clinical implication, and it exerts these effects possibly in ways other than surfactant modulation.


Asunto(s)
Ambroxol/administración & dosificación , Puente Cardiopulmonar/efectos adversos , Puente de Arteria Coronaria/efectos adversos , Enfermedades Pulmonares/prevención & control , Pulmón/efectos de los fármacos , Fármacos del Sistema Respiratorio/administración & dosificación , Administración Oral , Adulto , Líquido del Lavado Bronquioalveolar/química , Método Doble Ciego , Esquema de Medicación , Femenino , Volumen Espiratorio Forzado , Humanos , Lecitinas/metabolismo , Pulmón/metabolismo , Pulmón/fisiopatología , Enfermedades Pulmonares/etiología , Enfermedades Pulmonares/metabolismo , Enfermedades Pulmonares/fisiopatología , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Atención Perioperativa , Esfingomielinas/metabolismo , Resultado del Tratamiento , Capacidad Vital
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...